Kamrooz Ghadimi, MD
Critical Care Medicine · Durham, NCNPI 1346510682
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,000 of the $4,524 with a category attached, or 88.4%. Octapharma USA, Inc. accounts for 91.5% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $4,140, more than ten times the $89 reported in 2022.
Across 7 payments — averaging $646.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Octapharma USA, Inc.$4K
- Edwards Lifesciences$294
- Hemosonics LLC$89
Across 34 payments — averaging $31,337 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Octapharma USA, Inc.$1.1M
What the payments were for
- Speaking & faculty fees$4,00088%
- Travel & lodging$1403%
- Food & beverage$3848%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Octapharma USA, Inc. | 2 | $4,140 |
| Edwards Lifesciences | 4 | $294 |
| Hemosonics LLC | 1 | $89 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FIBRYGA & BALFAXAR$4,140
How this compares
$4,524 in reported general payments places this provider in the 85th percentile of 190 critical care medicine providers in North Carolina.
See all critical care medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Durham
- Neil MacintyreDurham$70K
- Yuh Chin HuangDurham$16K
- Lingye ChenDurham$3K
- Marija SullivanDurham$2K
- Cherylee ChangDurham$827
- Alexis SmithHuntersville$726K
- Rabih BecharaCharlotte$453K
- Ashish KhannaWinston Salem$364K
- Alan HeffnerCharlotte$326K
- Daniel FeinsteinPinehurst$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.